Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152130 | SCV000200822 | benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | Pro89Ala in Exon 05 of TRIOBP: This variant is not expected to have clinical sig nificance because it has been identified in 0.8% (54/6636) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS). |
Eurofins Ntd Llc |
RCV000152130 | SCV000230983 | benign | not specified | 2015-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000955605 | SCV000730247 | benign | not provided | 2018-08-20 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function |
Labcorp Genetics |
RCV000955605 | SCV001102318 | likely benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000955605 | SCV002544727 | likely benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | TRIOBP: BP4, BS1 |
Fulgent Genetics, |
RCV002478433 | SCV002802751 | likely benign | Autosomal recessive nonsyndromic hearing loss 28 | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000955605 | SCV005206416 | likely benign | not provided | criteria provided, single submitter | not provided |